A Prospective Phase II Study of Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Press/Media

Period23 Dec 2024

Media coverage

1

Media coverage

  • TitleA Prospective Phase II Study of Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date23/12/24
    PersonsJennifer Yang
View all 1
View less